Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Alonzi, Roberto"" wg kryterium: Autor


Tytuł :
Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb)
Autorzy :
Bhattacharya, Indrani S.
Taghavi Azar Sharabiani, Mansour
Alonzi, Roberto
Hoskin, Peter J.
Pokaż więcej
Temat :
Angiogenesis
Biomarkers
Brachytherapy
Hypoxia
Immunohistochemistry
Prostate cancer
Radiotherapy
Hematology
Oncology
Radiology Nuclear Medicine and imaging
Źródło :
Bhattacharya, I S, Taghavi Azar Sharabiani, M, Alonzi, R & Hoskin, P J 2019, ' Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb) ', Radiotherapy and Oncology, vol. 137, pp. 38-44 . https://doi.org/10.1016/j.radonc.2019.04.019
Opis pliku :
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Tytuł :
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Autorzy :
Parker, Christopher C
James, Nicholas D
Brawley, Christopher D
Clarke, Noel W
Hoyle, Alex P
Ali, Adnan
Ritchie, Alastair W S
Attard, Gerhardt
Chowdhury, Simon
Cross, William
Dearnaley, David P
Gillessen, Silke
Gilson, Clare
Jones, Robert J
Langley, Ruth E
Malik, Zafar I
Mason, Malcolm D
Matheson, David
Millman, Robin
Russell, J Martin
Thalmann, George N
Amos, Claire L
Alonzi, Roberto
Bahl, Amit
Birtle, Alison
Din, Omar
Douis, Hassan
Eswar, Chinnamani
Gale, Joanna
Gannon, Melissa R
Jonnada, Sai
Khaksar, Sara
Lester, Jason F
O'sullivan, Joe M
Parikh, Omi A
Pedley, Ian D
Pudney, Delia M
Sheehan, Denise J
Srihari, Narayanan Nair
Tran, Anna T H
Parmar, Mahesh K B
Sydes, Matthew R
Pokaż więcej
Temat :
610 Medicine & health
Article
Źródło :
Parker, C C, James, N D, Brawley, C D, Clarke, N W, Hoyle, A P, Ali, A, Ritchie, A W S, Attard, G, Chowdhury, S, Cross, W, Dearnaley, D P, Gillessen, S, Gilson, C, Jones, R J, Langley, R E, Malik, Z I, Mason, M D, Matheson, D, Millman, R, Russell, J M, Thalmann, G N, Amos, C L, Alonzi, R, Bahl, A, Birtle, A, Din, O, Douis, H, Eswar, C, Gale, J, Gannon, M R, Jonnada, S, Khaksar, S, Lester, J F, O'sullivan, J M, Parikh, O A, Pedley, I D, Pudney, D M, Sheehan, D J, Srihari, N N, Tran, A T H, Parmar, M K B & Sydes, M R 2018, ' Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial ', The Lancet . https://doi.org/10.1016/S0140-6736(18)32486-3
Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators 2018, ' Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial ', Lancet, vol. 392, no. 10162, pp. 2353-2366 . https://doi.org/10.1016/S0140-6736(18)32486-3
Parker, Christopher C; James, Nicholas D; Brawley, Christopher D; Clarke, Noel W; Hoyle, Alex P; Ali, Adnan; Ritchie, Alastair W S; Attard, Gerhardt; Chowdhury, Simon; Cross, William; Dearnaley, David P; Gillessen, Silke; Gilson, Clare; Jones, Robert J; Langley, Ruth E; Malik, Zafar I; Mason, Malcolm D; Matheson, David; Millman, Robin; Russell, J Martin; ... (2018). Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet, 392(10162), pp. 2353-2366. Elsevier 10.1016/S0140-6736(18)32486-3
Opis pliku :
application/pdf
Tytuł :
UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer.
Autorzy :
Graves, Martin
Barnes, Anna
Alonzi, Roberto
Blackledge, Matthew
Charles-Edwards, Geoff
Collins, David J
Cook, Gary
Coutts, Glynn
Goh, Vicky
Kelly, Charles
Koh, Dow-Mu
McCallum, Hazel
Miquel, Marc E
O'Connor, James
Padhani, Anwar
Pearson, Rachel
Priest, Andrew
Rockall, Andrea
Stirling, James
Taylor, Stuart
Tunariu, Nina
Van Der Meulen, Jan
Walls, Darren
Winfield, Jessica
Punwani, Shonit
Pokaż więcej
Temat :
Medical Oncology
Whole Body Imaging
Diffusion Magnetic Resonance Imaging
Quality Control
United Kingdom
PHYSICS AND TECHNOLOGY - Magnetic resonance
Diagnostic Radiology
Neoplasms
Guidelines & Recommendations
RADIODIAGNOSIS - Techniques/Subspecialties
Humans
PHYSICS AND TECHNOLOGY - Diagnostic radiology physics
Źródło :
Br J Radiol (2017) (In press).
The British Journal of Radiology
Barnes, A, Alonzi, R, Blackedge, M, Charles-Edwards, G, Collins, D, Cook, G, Coutts, G, Goh, V J-L, Graves, M, Kelly, C, Koh, D-M, McCallum, H, Miquel, M, O'Connor, J, Padhani, A, Pearson, R, Priest, A, Rockall, A, Stirling, J, Taylor, S, Tunariu, N, Van Der Meulen, J, Walls, D, Winfield, J & Punwani, S 2017, ' UK quantitative WB-DWI technical workgroup : Consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer ', British Journal of Radiology, vol. 91, no. 20170577, 20170577 . https://doi.org/10.1259/bjr.20170577
Opis pliku :
application/pdf; text
Tytuł :
High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer:acute toxicity
Autorzy :
Hoskin, Peter
Rojas, Ana
Ostler, Peter
Hughes, Robert
Alonzi, Roberto
Lowe, Gerry
Bryant, Linda
Pokaż więcej
Temat :
Aged
Brachytherapy/adverse effects
Dose-Response Relationship, Radiation
Gastrointestinal Diseases/etiology
Humans
Iridium Radioisotopes/administration & dosage
Male
Middle Aged
Prostatic Neoplasms/radiotherapy
Radiation Injuries/etiology
Rectum/radiation effects
Urethra/radiation effects
Urologic Diseases/etiology
Źródło :
Hoskin, P, Rojas, A, Ostler, P, Hughes, R, Alonzi, R, Lowe, G & Bryant, L 2014, ' High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer : acute toxicity ', Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol. 110, no. 2, pp. 268-71 . https://doi.org/10.1016/j.radonc.2013.09.025

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies